Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Blood
|
May 5, 2005
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes
Friedrich Feuerhake, Jeffery L Kutok, Stefano Monti, et al.
Cancer Research
|
February 5, 2024
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer
Alessandra Rigamonti, Marika Viatore, Rebecca Polidori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Proinflammatory Macrophage Activation by the Polysialic Acid-Siglec-16 Axis Is Linked to Increased Survival of Patients with Glioblastoma
Hauke Thiesler, Lina Gretenkort, Leonie Hoffmeister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial
Monika Graeser, Oleg Gluz, Peter Schmid, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
Monika Graeser, Friedrich Feuerhake, Oleg Gluz, et al.
Frontiers in Oncology
|
January 29, 2021
PD-1 Blockade Aggravates Epstein-Barr Virus<sup>+</sup> Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4<sup>+</sup> T Cell Dysregulations
Valery Volk, Sebastian J Theobald, Simon Danisch, et al.
Gastroenterology
|
March 5, 2021
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
Stefan Schreiber, Konrad Aden, Joana P Bernardes, et al.
Blood
|
November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Stefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2026
Stroma-driven inter- and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation
Anna Saborowski, Simon Peters, Jinbo Zhao, et al.
Blood
|
August 23, 2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
Kerry J Savage, Stefano Monti, Jeffery L Kutok, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Blood
|
May 5, 2005
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes
Friedrich Feuerhake, Jeffery L Kutok, Stefano Monti, et al.
Cancer Research
|
February 5, 2024
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer
Alessandra Rigamonti, Marika Viatore, Rebecca Polidori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Proinflammatory Macrophage Activation by the Polysialic Acid-Siglec-16 Axis Is Linked to Increased Survival of Patients with Glioblastoma
Hauke Thiesler, Lina Gretenkort, Leonie Hoffmeister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial
Monika Graeser, Oleg Gluz, Peter Schmid, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2021
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
Monika Graeser, Friedrich Feuerhake, Oleg Gluz, et al.
Frontiers in Oncology
|
January 29, 2021
PD-1 Blockade Aggravates Epstein-Barr Virus<sup>+</sup> Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4<sup>+</sup> T Cell Dysregulations
Valery Volk, Sebastian J Theobald, Simon Danisch, et al.
Gastroenterology
|
March 5, 2021
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
Stefan Schreiber, Konrad Aden, Joana P Bernardes, et al.
Blood
|
November 20, 2004
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Stefano Monti, Kerry J Savage, Jeffery L Kutok, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2026
Stroma-driven inter- and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation
Anna Saborowski, Simon Peters, Jinbo Zhao, et al.
Blood
|
August 23, 2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
Kerry J Savage, Stefano Monti, Jeffery L Kutok, et al.
Page
of 8